BIOLOGICAL EFFECT OF ORALLY ACTIVE PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST SM-10661

被引：0
|
作者：
KOMURO, Y [1 ]
IMANISHI, N [1 ]
UCHIDA, M [1 ]
MOROOKA, S [1 ]
机构：
[1] SUMITOMO PHARMACEUT CO LTD,RES LABS,1-98 KASUGADE NAKA 3 CHOME,KONAHANA KU,OSAKA 554,JAPAN
来源：
MOLECULAR PHARMACOLOGY | 1990年 / 38卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：378 / 384
页数：7
相关论文
共 50 条
  • [21] SM-12502: A platelet activating factor antagonist
    Morooka, S
    Koike, H
    Imanishi, N
    Natsume, Y
    CARDIOVASCULAR DRUG REVIEWS, 1995, 13 (02): : 105 - 122
  • [22] EFFECT OF THE SELECTIVE PAF ANTAGONIST SM-10661 ON AN ASTHMATIC MODEL .1. EFFECT ON PASSIVE ANAPHYLACTIC BRONCHOCONSTRICTION IN GUINEA-PIGS
    UCHIDA, M
    IMANISHI, N
    SUGASAWA, T
    MOROOKA, S
    LIPIDS, 1991, 26 (12) : 1301 - 1304
  • [23] Lexipafant (BB-882): A potent new platelet-activating factor receptor antagonist
    Abu-Zidan, FM
    Walther, S
    Lennquist, S
    CARDIOVASCULAR DRUG REVIEWS, 1997, 15 (03): : 232 - 243
  • [24] Modulation of hypoxic ventilatory response by systemic platelet-activating factor receptor antagonist in the rat
    Simakajornboon, N
    Graff, GR
    Torres, JE
    Gozal, D
    RESPIRATION PHYSIOLOGY, 1998, 114 (03): : 213 - 225
  • [25] Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
    Albert, DH
    Magoc, TJ
    Tapang, P
    Luo, GJ
    Morgan, DW
    Curtin, M
    Sheppard, GS
    Xu, LH
    Heyman, HR
    Davidsen, SK
    Summers, JB
    Carter, GW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (01) : 69 - 80
  • [26] CHARACTERIZATION OF CUTANEOUS VASCULAR-PERMEABILITY INDUCED BY PLATELET-ACTIVATING FACTOR IN GUINEA-PIGS AND RATS AND ITS INHIBITION BY A PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST
    HWANG, SB
    LI, CL
    LAM, MH
    SHEN, TY
    LABORATORY INVESTIGATION, 1985, 52 (06) : 617 - 630
  • [27] PLATELET-ACTIVATING FACTOR AND HYPERACUTE REJECTION - THE EFFECT OF A PLATELET-ACTIVATING FACTOR ANTAGONIST, SRI 63-441, ON REJECTION OF XENOGRAFTS AND ALLOGRAFTS IN SENSITIZED HOSTS
    MAKOWKA, L
    CHAPMAN, FA
    CRAMER, DV
    QIAN, SG
    SUN, H
    STARZL, TE
    TRANSPLANTATION, 1990, 50 (03) : 359 - 365
  • [28] THE EFFECT OF THE ORALLY-ACTIVE PLATELET-ACTIVATING-FACTOR ANTAGONIST WEB-2086 IN THE TREATMENT OF ASTHMA
    SPENCE, DPS
    JOHNSTON, SL
    CALVERLEY, PMA
    DHILLON, P
    HIGGINS, C
    RAMHAMADANY, E
    TURNER, S
    WINNING, A
    WINTER, J
    HOLGATE, ST
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) : 1142 - 1148
  • [29] Inactive and constitutively active forms of the human platelet-activating factor receptor.
    LeGouill, C
    Parent, JL
    deBrumFernandes, JL
    RolaPleszczynski, M
    Stankova, J
    FASEB JOURNAL, 1996, 10 (03): : 3970 - 3970
  • [30] Effect of platelet-activating factor receptor expression on CHO cell motility
    Boccellino, M
    Biancone, L
    Cantaluppi, V
    Ye, RD
    Camussi, G
    JOURNAL OF CELLULAR PHYSIOLOGY, 2000, 183 (02) : 254 - 264
12345